Popular RX drug with new recommended dosage reduces risk of cancer relapse


POSTED: Thursday, May 1, 2014 - 6:25pm

UPDATED: Thursday, May 1, 2014 - 6:38pm

Tamoxifen is the leading drug used to treat pre-menopausal women for breast cancer. The drug has been prescribed since 1980, and can reduce the risk of cancer coming back, by 50 percent.

Previously Tamoxifen required patients to use the drug for 5 years, but research from an Atlas study shows it is more effective to use for 10 years. KETK spoke with Dr. Jivesh Sharma from the Blood and Cancer Center, who said, "The main goal of what therapy can offer is to control the cancer, and then Tamoxifen is part of the toolbox of medicines that we use". For women under 60, Tamoxifen is the primary drug used after chemotherapy. Dr. Sasha Vukelja from Texas Oncology said, "It is the only drug for pre-menopausal women".

Many are excited about the drugs effectiveness, and our own community continues to fight against cancer through the annual "Race for the Cure" event. This year, the race will begin on May 10, 2014. Dr. Vukelja said, "It increases the awareness, It's a great weekend it's Mother's Day weekend, and I love to see thousands and thousands of women with pink running. I just love that". However, it's important to remember that breast cancer awareness should be every day.

To sign up for the event visit: http://www.komentyler.org/komen-race-for-the-cure/race-information/ .

Comments News Comments

Post new Comment